Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seretide for Asthma in Elite Athletes
NCT00262587Phase 4Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Sep 2005
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Seretide with Placebo (2 arms). Primary endpoints: Eucapnic voluntary hyperventilation and Exhaled Nitric Oxide. Started Sep 2005; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00262587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262587.